(MIT Technology Review) – The first clinical trial of a therapy bot that uses generative AI suggests it was as effective as human therapy for participants with depression, anxiety, or risk for developing eating disorders. Even so, it doesn’t give a go-ahead to the dozens of companies hyping such technologies while operating in a regulatory gray area.

A team led by psychiatric researchers and psychologists at the Geisel School of Medicine at Dartmouth College built the tool, called Therabot, and the results were published on March 27 in NEJM AI, a journal by the New England Journal of Medicine. (Read More)